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Abstract
Background: A number of epidemiologic studies have observed an association between secondhand smoke (SHS) exposure
and pediatric invasive bacterial disease (IBD) but the evidence has not been systematically reviewed. We carried out a
systematic review and meta-analysis of SHS exposure and two outcomes, IBD and pharyngeal carriage of bacteria, for
Neisseria meningitidis (N. meningitidis), Haemophilus influenzae type B (Hib), and Streptococcus pneumoniae (S. pneumoniae).
Methods and Findings: Two independent reviewers searched Medline, EMBASE, and selected other databases, and
screened articles for inclusion and exclusion criteria. We identified 30 case-control studies on SHS and IBD, and 12 cross-
sectional studies on SHS and bacterial carriage. Weighted summary odd ratios (ORs) were calculated for each outcome and
for studies with specific design and quality characteristics. Tests for heterogeneity and publication bias were performed.
Compared with those unexposed to SHS, summary OR for SHS exposure was 2.02 (95% confidence interval [CI] 1.52–2.69)
for invasive meningococcal disease, 1.21 (95% CI 0.69–2.14) for invasive pneumococcal disease, and 1.22 (95% CI 0.93–1.62)
for invasive Hib disease. For pharyngeal carriage, summary OR was 1.68 (95% CI, 1.19–2.36) for N. meningitidis, 1.66 (95% CI
1.33–2.07) for S. pneumoniae, and 0.96 (95% CI 0.48–1.95) for Hib. The association between SHS exposure and invasive
meningococcal and Hib diseases was consistent regardless of outcome definitions, age groups, study designs, and
publication year. The effect estimates were larger in studies among children younger than 6 years of age for all three IBDs,
and in studies with the more rigorous laboratory-confirmed diagnosis for invasive meningococcal disease (summary OR
3.24; 95% CI 1.72–6.13).
Conclusions: When considered together with evidence from direct smoking and biological mechanisms, our systematic
review and meta-analysis indicates that SHS exposure may be associated with invasive meningococcal disease. The
epidemiologic evidence is currently insufficient to show an association between SHS and invasive Hib disease or
pneumococcal disease. Because the burden of IBD is highest in developing countries where SHS is increasing, there is a
need for high-quality studies to confirm these results, and for interventions to reduce exposure of children to SHS.
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Invasive bacterial disease (IBD) is an important cause of child
mortality in developing and developed countries [1–7], accounting
for at least as many child deaths as HIV/AIDS and malaria
combined [6–8]. The organisms responsible for most pediatric IBD
cases are S. pneumoniae, Haemophilus influenzae type B (Hib), and N.
meningitidis [1,2,4,6,7,9]. In 2000, there were an estimated 14.5
million cases and 826,000 deaths from pneumococcal disease in
children under 5 with estimated incidence ranging from 544 per
100,000 in the Americas to 1,778 per 100,000 in Africa [6]. The
burden of Hib was estimated at 8.13 million cases and 371,000
deaths with estimated incidence ranging from 504 per 100,000 in
Europe to 3,627 per100,000inAfrica [7]. While therearecurrently
no analyses of global invasive meningococcal disease burden,
regional estimates of incidence range from 0.3 to 4 cases per
100,000 in North America to as high as 1,000 cases per 100,000 in
the so-called ‘‘meningitis belt’’ in sub-Saharan Africa [9].
Secondhand smoke (SHS; also referred to as involuntary smoking,
passive smoking, or environmental tobacco smoke [ETS]) has been
shown to increase the risk of several adverse outcomes in children,
including lower respiratory tract infections, middle ear infection,
asthma, and sudden infant death syndrome [10,11]. Since the 1980s,
epidemiologic studies have also found an association between SHS
exposure and IBD or bacterial carriage, including those related to N.
meningitidis,H i b ,a n dS. pneumoniae, which suggests that SHS might be
an independent risk factor for IBD. Given the persistent or growing
SHS exposure in developing countries, especially in Asia, where IBD
poses a major health risk, it is essential to delineate the role of
exposure to SHS in the epidemiology of IBD. To our knowledge, no
reviews have systematicallyinvestigated the quality and consistency of
epidemiological evidence on this association, which is an important
gap in our understanding of the effect of SHS exposureon the burden
of infectious diseases. We carried out a systematic review and
quantitative assessment of the association between SHS and the risk
of IBD from N. meningitidis,H i b ,a n dS. pneumoniae in pediatric
populations, aged 1 mo to 19 y (see below). We also included the
effects of SHS exposure on pharyngeal carriage of these three
bacteria because asymptomatic carriageisalsoassociated withclinical
disease [12–16].
Methods
Search Strategy
We carried out a systematic literature search of SHS and IBD
using Medline (via PubMed), and EMBASE from 1975 through
December 2009. PubMed was searched by combining two separate
queriescomposed ofmedicalsubject heading(MeSH)and text word
(tw) keywords for the exposure and outcome of interest. The first
(exposure) query was searched using the following exploded
headings and independent terms: ‘‘(cigarette smoke[tw] OR
‘‘tobacco smoke pollution’’[MeSH] OR ‘‘cotinine’’[MeSH] OR
tobacco smoke[tw] OR passive smoking[tw] OR secondhand
smoke[tw] OR second hand smoke[tw] OR parental smoking[tw]
OR paternal smoking[tw] OR maternal smoking[tw] OR cotini-
ne[tw]).’’ The second (outcome) query was searched using exploded
headingsandindependent termsforallthreebacterialformsofIBD:
(‘‘pneumococcal infections’’[MeSH] OR ‘‘Streptococcus pneumoniae’’
[MeSH] OR ‘‘Haemophilus influenzae’’[MeSH] OR ‘‘Neisseria meningi-
tidis’’[MeSH] OR ‘‘Sepsis’’[MeSH] OR ‘‘Meningitis, Meningococ-
cal’’[MeSH] OR ‘‘Haemophilus Infections’’[MeSH] OR meningo-
coccemia[tw] OR meningococcal[tw] OR pneumococcal[tw] OR
Haemophilus influenzae[tw] OR h influenzae[tw] OR h influenza[tw]
OR Neisseria meningitidis[tw]).’’
We used manual restriction by age and study type (versus using
automated methods in PubMed) to avoid unnecessarily eliminating
any articles relevant to the search. A similar search strategy and
search terms were used in EMBASE. The searches and studies
included were not limited by publication date, country, or language.
PubMed and EMBASE searches were conducted independently by
two authors (C-CL and NAM). To ensure comprehensive acquisition
of literature, independent supplemental manual searches were
performed on the reference lists of relevant articles and other minor
databases, including Web of Science, Cochrane databases, Centers
for Disease Control and Prevention Smoking and Health Database,
China National Knowledge Infrastructures (CNKI), Latin American
and Caribbean of Health Sciences Information System (LILACS),
andAfrican IndexMedicus (AIM). Medical Subject Heading (MeSH)
andEMbase TREEtool (EMTREE)wereused toguide the choiceof
appropriate search terms in other databases.
Inclusion and Exclusion
Two reviewers independently identified articles eligiblefor in-depth
examination using the following inclusion and exclusion criteria.
Studies were included if at least one of the following outcomes was
analyzed: invasive S. pneumoniae disease, invasive Hib disease, invasive
N. meningitidis disease, and naso- or oropharyngeal carriage of any of
the above three bacteria. IBD was defined as bacterial meningitis,
bacterial epiglottitis, bacteremia, or microbiologically documented
infection at other normally sterile sites with relevant clinical syndrome.
Relevant exposures were defined as SHS or ETS exposure, parental
smoking, household smoking or presence of household smoker(s), and
regular contact with smokers. We excluded studies in which active
smoking was the only exposure, active smoking was not distinguished
from passive smoking, or studies that also included prenatal exposure.
Study types included were cohort, case-control, and cross-sectional
surveys, whereas case reports, review articles, editorials, and clinical
guidelines were excluded. We included studies on human participants
aged 1 mo to 19 y, i.e. infants, children, and adolescents. We excluded
the neonatal period because of its established epidemiologic and
pathophysiologic distinction from the post-neonatal period [17]. We
included adolescents because age-specific N. meningitidis incidence
peaks in childhood as well as adolescence; while S. pneumoniae
incidence peaks in childhood and infancy, this disease may also occur
in adolescents [4,6,9].
Studies on immunocompromised populations were excluded.
When multiple articles reported on the same study population, we
included only the most detailed publication that met the inclusion
criteria. Any discrepancies on articles meriting inclusion between
reviewers were resolved by a consensus meeting of three authors
(C-CL, NAM, and ME). Study selection is summarized in Figure 1.
Data Extraction and Synthesis
Data were extracted on study location, setting (e.g., community,
school, hospital, etc.), population characteristics including age
range and sex ratio, number of participants, definition of exposure
and diagnosis of outcome, crude and adjusted effect sizes as
available, and confidence intervals (CIs). We also recorded quality
indicators of study design including presence of appropriate
controls and covariates used for adjustment in multivariate
analysis. We conducted separate analyses on IBD and bacterial
carriage. When studies were identified as containing pertinent data
not included in the published article (e.g., when they did not
differentiate between pediatric and adult participants), we
contacted the authors to obtain the missing data. When a response
was not provided and raw data were provided in the article, we
manually calculated the unadjusted odds ratio (OR) for inclusion
in the meta-analysis. Otherwise, such articles were excluded.
SHS and Pediatric Invasive Bacterial Disease
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We followed the PRISMA guidelines for meta-analysis of
observational studies in our data extraction, analysis, and
reporting (Text S1) [18]. Heterogeneity was tested using the
Cochran Q statistic (p,0.05) and quantified with the I
2 statistic,
which describes the variation of effect size that is attributable to
heterogeneity across studies [19,20]. The value of the I
2 statistic
was used to select the appropriate pooling method: fixed-effects
models were used for I
2,50% and random-effects models for I
2
$50% [19,20]. CIs of I
2 were calculated by the methods suggested
by Higgins et al. [21]. Pooled ORs were summarized with
Mantel–Haenszel method for fixed-effect models and DerSimo-
nian and Laird method for random effect models [20]. Galbraith
plots were used to visualize the impact of individual studies on the
overall homogeneity test statistic [22]. Meta-regression was used to
evaluate whether effect size estimates were significantly different
by specific study characteristics and quality factors, particularly
those of adjustment for covariates and whether IBD diagnosis was
only the more rigorous laboratory-confirmed or a mix of clinical-
only and laboratory-confirmed diagnosis. We defined a study as
having laboratory-confirmed diagnosis as the primary outcome if
the study had more than 80% of cases confirmed by a positive
culture, rapid antigen test, or PCR-based identification. In
addition to meta-regression, we reestimated effects size stratified
on the same study characteristics and quality factors, so that they
are available as separate estimates. Even when the meta-regression
result was not statistically significant, we conducted a subgroup
analysis when a study characteristic was clinically or epidemio-
logically relevant, e.g., the age range of study participants.
The presence and the effect of publication bias was examined
using a combination of the Begg and Egger tests and the ‘‘trim and
fill’’ procedure [19,23,24]. This procedure considers the hypo-
thetical possibility of studies that were missed, imputes their ORs,
and recalculates a pooled OR that incorporates these hypothetical
missing studies [23]. Trim-and-fill ORs are reported when the
tests for publication bias were significant.
Statistical analyses were performed using Stata 10.1 (Stata-
Corp). The metan, metabias, galbr, metareg, and metatrim
macros were used for meta-analytic procedures. p-Values ,0.05
were considered statistically significant.
Results
Search Results and Study Characteristics
Our search identified a total of 198 studies, of which 95 were
from PubMed and 103 from EMBASE. Screening based on title
and abstract identified 62 citations for full-text review (Figure 1).
An additional 27 studies were identified from reference lists of the
identified articles and from other databases. Of the 89 potentially
relevant articles, 47 were excluded for reasons in Figure 1, leaving
a total of 42 studies that met the inclusion criteria.
There were 30 studies on invasive disease and 12 on pharyngeal
carriage. All invasive disease studies utilized a case-control design
and all carriage studies were cross-sectional studies. The studies
varied in their SHS exposure metric, age range, and case
definition (Table 1). Household smoking or the presence of
household smokers was the most frequent measure of SHS
exposure (26 of 42 studies), while most others used maternal,
paternal, or caregiver smoking. Nineteen of 30 invasive disease
studies used laboratory-confirmed diagnosis as the case definition
for all participants, while others had individuals with a
combination of clinical-only and laboratory-confirmed diagnosis.
Where clinical diagnoses were included, they were specific to the
organism, including hemorrhagic rash for invasive meningococcal
disease and epiglottitis for invasive Hib disease. The inclusion of
carefully clinically defined cases has the potential to reduce bias in
settings where pre-referral antibiotic treatment is common, either
by policy or because of wide availability of antibiotics in the
community. All 12 bacterial carriage studies used a culture
definition, eight from nasopharyngeal swabs and the remainder
from oropharyngeal swabs. The studies also varied in covariates
adjusted for as shown in Table 1.
SHS Exposure and IBD
Invasive meningococcal disease. The 16 studies with
invasive meningococcal disease as the primary outcome included
a total of 1,948 cases and 13,734 controls (Table 1) [25–41]. When
the results from all studies were combined, SHS exposure was
associated with an increased risk of invasive meningococcal disease
(pooled OR 2.02, 95% CI 1.52–2.69; test of heterogeneity
p,0.001, I
2=68.5%) (Figure 2A). Galbraith plots showed that
two studies from Australia and Ghana were potential sources of
heterogeneity [30,37]. The effect estimate excluding these two
studies was slightly reduced compared with the overall effect
estimate (OR 1.79, 95% CI 1.56–2.05).
Meta-regression analysis did not show any significant effect size
modification by the specific study characteristics considered,
possibly because of a relatively small number of studies (Table 2).
In subgroup analyses, the association was larger in studies that
used laboratory-confirmed cases (OR 3.24, 95% CI 1.72–6.13)
[27,28,31–33,39]. Subgroup analysis of studies with different
covariate adjustment generally found similar magnitude and
direction of ORs compared with the overall effect size (Table 2)
[25–28,30–34,36–40]. When the analysis was restricted to the
three studies on preschool children (age #6 y), the association was
stronger but nonsignificant (OR 3.04, 95% CI 0.89–10.47)
[28,33,39].
Invasive pneumococcal disease. The four case-control
studies on SHS exposure and invasive pneumococcal disease
included a total of 412 cases and 842 controls (Table 1)
[35,36,42,43]. Combined results from all studies yielded a
nonsignificant association (pooled OR 1.21, 95% CI 0.69–2.14;
test of heterogeneity p=0.098, I
2=52.3%) (Figure 2B). Once
again, meta-regression did not show any significant effect size
modification by specific study characteristics considered (Table 2).
Figure 1. Flow chart of study identification and inclusion.
doi:10.1371/journal.pmed.1000374.g001
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Study (Location,
Year) Design
Setting and Study
Population Sample Size Exposure
a Case Ascertainment
b
Adjustment in Multivariate
Analysis
Invasive
meningococcal
disease
Haneberg et al.
(Norway, 1983) [29]
Case-control Population-based,
younger than 12 y
469 (case 115) Parental or household
smoking
Laboratory-confirmed
and/or clinical diagnosis
Only unadjusted ORs reported
Stuart et al.
(UK, 1988) [40]
Case-control Population-based,
younger than 12 y
140 (case 70) Household smoking Laboratory-confirmed
and/or clinical diagnosis
Only unadjusted ORs reported
Stanwell-Smith et al.
(UK, 1994) [39]
Case-control Population-based,
younger than 5 y
152 (case 38) Household smoking Laboratory-confirmed
diagnosis
Only unadjusted ORs reported
Fischer et al.
(US, 1997) [27]
Case-control Population-based,
younger than 18 y
259 (case 84) Maternal smoking at
home
Laboratory-confirmed
diagnosis
Age, location, maternal
education, lack of primary care
physician, household member
density, school children density,
humidifier use, church
attendance
Moodley et al.
(South Africa,
1999) [34]
Case-control Population-based,
younger than 14 y
280 (case 70) Two or more household
smokers
Laboratory-confirmed
and/or clinical
diagnosis
Age, breastfeeding, crowding
index, recent respiratory tract
infection, weight for age z-score
Baker et al. (New
Zealand, 2000) [25]
Case-control Population-based,
younger than 8 y
515 (case 202) Household smoking Laboratory-confirmed
and/or clinical
diagnosis
Number of household members,
analgesic use, attendance of
social gathering, food sharing,
household member respiratory
tract infection symptom,
recent respiratory tract infection,
bed sharing
Kriz et al. (Czech
Republic,
2000) [32]
Case-control Population-based,
younger than 15 y
203 (case 68) Number of cigarettes
smoked in the house in
multiples of 20
Laboratory-confirmed
diagnosis
Mother’s and father’s education,
ownership of car and cottage,
crowding
Hodgson A, et al.
(Ghana, 2001) [30]
Case-control Population-based,
younger than 15 y
398 (case 201) Compound (household)
smoking
Laboratory-confirmed
and/or clinical diagnosis
Only unadjusted ORs reported
Robinson et al.
(Australia,
2001) [37]
Case-control Population-based,
younger than 16 y
141 (case 47) Parent or partner
smoking
Laboratory-confirmed
and/or clinical
diagnosis
Contact with dust, shared
bedroom, any illness in
prior 2 wk, oral muscle tone
deficiency
Grein et al. (Ireland,
2001) [28]
Case-control Population-based,
younger than 6 y
354 (case 87) Household smoking Laboratory-confirmed
diagnosis
Daycare attendance, number
of children under 6 y old in
household, number of adults
in household, crowding index
Sorensen et al.
(Denmark,
2004) [38]
Nested
case-control
Nationwide
population-based,
younger than 18 y
9,702 (case 462) Maternal smoking at
home
ICD-8 and ICD-10 codes
(treated as laboratory-
confirmed and/or
clinical diagnosis)
Low birth weight and
prematurity, family income,
crowding index
McCall et al.
(Australia, 2004) [33]
Case-control Population-based,
younger than 6 y
49 (case 21) Household smoking Laboratory-confirmed
diagnosis
Breastfeeding, room
sharing, daycare attendance
Pereiro et al.
(Spain, 2004) [36]
Case-control Hospital-based,
younger than 15 y
424 (case 181) Household smoking
($60 cigarettes/day)
c
Laboratory-confirmed
diagnosis and/or
clinical diagnosis
More than four household
members, meningococcal
vaccination
Coen et al. (England,
2005) [26]
Case-control Population-based, 15–
19 y
288 (case 144) Latent variable for SHS
exposure based on 7
variables
Laboratory-confirmed
and/or clinical
diagnosis
Socioeconomic status,
individual’s occupation,
meningococcal vaccination
status
Tully et al. (UK, 2005)
[41]
Case-control Population-based, 15–
19 y
228 (case 114) Close contacts with
smokers
Laboratory-confirmed
and/or clinical diagnosis
Only unadjusted ORs reported
Honish et al.
(Canada, 2008) [31]
Case-control Population-based, 15–
19 y
132 (case 44) Maternal smoking Laboratory-confirmed
diagnosis
Use of humidifier, attended
rave, bar visits, maternal
education, visit to places
where smoking was allowed,
vaccination status
Meningococcal
carriage
Stuart et al.
(UK, 1989) [58]
Cross-sectional
survey
Population-based,
5–19 y
224 (case 112) Household smoking Nasopharyngeal carriage Only unadjusted ORs reported
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Year) Design
Setting and Study
Population Sample Size Exposure
a Case Ascertainment
b
Adjustment in Multivariate
Analysis
Kremastinou et al.
(Greece, 1994) [55]
Cross-sectional
survey
Population-based,
5–19 y
742 (case 44) Maternal or other
caretaker smoking
Oropharyngeal carriage,
saliva
Only unadjusted ORs reported
Davies AL, et al.
(UK,1996) [54]
Cross-sectional
survey
School contacts of
index case, 11–18 y
114 (case 18) Household smoking Nasopharyngeal carriage Only unadjusted ORs reported
Kremastinou et al.
(Greece, 1999) [56]
Cross-sectional
survey
Russian immigrants,
6–15 y
625 (case 82) Parental smoking Oropharyngeal carriage Only unadjusted ORs reported
MacLennan et al.
(UK, 2006) [57]
Cross-sectional
survey
Population-based,
15–19 y
13,919 (case
2,319)
Household smoking Oropharyngeal carriage Age, active smoking, intimate
kissing, pub attendance, number
of people in the bedroom,
household member density,
recent antibiotic use, school type,
school size, study sites
Invasive
pneumococcal
disease
Takala et al.
(Finland, 1995) [43]
Case-control Population-based,
,15 y
433 (case 149) Parental smoking
at home
Laboratory-confirmed
diagnosis
Only unadjusted ORs reported
O’Dempsey et al.
(Gambia, 1996) [35]
Case-control Population-based,
4–14.2 mo
239 (case 80) Paternal or other
household smoking
Laboratory-confirmed
and/or clinical diagnosis
Mother has income, cooking
smoke exposure, weight for age
z-score, illness in past month,
significant illness in past 6 mo
Pereiro et al.
(Spain, 2004) [36]
Case-control Hospital-based,
younger than 15 y
306 (case 63) Household smoking
($60 cigarettes/day)
c
Laboratory-confirmed
diagnosis
Only unadjusted ORs reported
Haddad et al.
(USA, 2008) [42]
Case-control Population-based,
younger than
59 mo
276 (case 120) Tobacco exposure (no
specific definition
provided)
Laboratory-confirmed
diagnosis
Only unadjusted ORs reported
Pneumococcal
carriage
Sung et al. (Hong
Kong, 1995) [63]
Cross-sectional
survey
Population-based,
2m ot o5y
921 (case 234) Household smoking Nasopharyngeal carriage Only unadjusted ORs reported
Coles et al.
(India, 2001) [60]
Cross-sectional
survey
South India
endemic area
population, 6 mo
464 (case 400) 20 or more cigarettes
per day were smoked
in the household
Nasopharyngeal carriage Sex, fed with colostrums, history
of night blindness during
pregnancy, fuel used for cooking,
season, maternal education,
transportation with bicycle,
number of siblings younger than
5 y, vitamin A supplementation
Greenberg et al.
(Israel, 2006) [61]
Cross-sectional
survey
Population-based, 1–
59 mo
208 (case 143) Parental smoking
at home
Nasopharyngeal carriage Only unadjusted ORs reported
Cardozo et al.
(Brazil, 2008) [59]
Cross-sectional
survey
Population-based, 10–
19 y
1,013 (case 83) Household smoking Nasopharyngeal carriage Age, sex, presence of siblings
younger than 5 y of age, upper
respiratory tract infection, acute
asthma
Labout et al.
(Netherlands, 2008)
[62]
Cross-sectional
d Population-based,
1.5 mo
757 (case 337) Maternal smoking
at home
Nasopharyngeal carriage Birth weight, gestational age,
parity, sex, maternal education,
having siblings
Invasive Hib disease
Cochi et al.
(USA, 1986) [45]
Case-control Population-based,
younger than 5 y
619 (case 89) Parental smoking Laboratory-confirmed
and/or clinical diagnosis
Only unadjusted ORs reported
Harrison et al.
(USA, 1989) [3]
Case-control Population-based,
younger than 5 y
201(Case 74) Parental smoking Laboratory-confirmed
diagnosis
Sex, race, income, age, maternal
education, number of rooms in
house, breastfeeding
Takala et al.
(Finland, 1989) [46]
Case-control Population-based,
1 month to 6 y
342 (case 117) Parental smoking Laboratory-confirmed
diagnosis
Only unadjusted ORs reported
Vadheim et al.
(USA,1992) [47]
Case-control Population-based,
18–60 mo
300 (case 79) Two or more
household smokers
Laboratory-confirmed
diagnosis
Age, month of diagnosis, Hib
vaccine status, household size,
annual household income,
number of children under 5 y
old, household density
breastfeeding, ethnicity, daycare
attendance
Table 1. cont.
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had a large but imprecise effect estimate (OR 2.99, 95% CI 1.10–
8.14) [35]. In subgroup analysis, the three studies with laboratory-
confirmed diagnosis had a null effect size of 0.93 (95% CI 0.62–
1.41). The association was stronger in studies on preschool
children, but remained nonsignificant (OR 1.68, 95% CI 0.61–
4.66) (Table 2) [35,42]. Studies before 2000, when pneumococcal
vaccines (including the 7-valent pneumococcal conjugate vaccine)
were not widely available, also showed a stronger but
nonsignificant association (OR 1.33, 95% CI 0.58–3.02) (Table 2)
[3,44–47].
Invasive Hib disease. The 12 case-control studies on SHS
exposure and invasive Hib disease included a total of 1,228 cases
and 3,076 controls (Table 1) [3,36,44–53]. The overall effect size
was positive but nonsignificant (pooled OR 1.22, 95% CI 0.93–
1.62; test of heterogeneity p=0.011, I
2=55.0%) (Figure 2C).
Excluding a study in Finland that was a potential source of
heterogeneity led to a lower pooled effect size, which remained
nonsignificant (OR 1.18, 95% CI 0.99–1.41) [46]. Of study
characteristics assessed in meta-regression, only being among
preschool children was statistically significant (Table 2). In
subgroup analysis, studies with laboratory-confirmed diagnosis
had a similar effect size of 1.24 (95% CI 0.86–1.78), whereas
adjusted studies yielded a lower and nonsignificant effect size (OR
1.10, 95% CI 0.80–1.51) [3,36,44,46–53]. Studies on preschool
children had a significant positive association (OR 1.46, 95% CI
1.19–1.81) (Table 2) [3,36,44–47,49,52,53]. Studies before 1990,
when Hib vaccine was not yet commonly available, had a stronger
Study (Location,
Year) Design
Setting and Study
Population Sample Size Exposure
a Case Ascertainment
b
Adjustment in Multivariate
Analysis
Arnold et al.
(USA,1993) [44]
Case-control Population-based,
younger than 6 y
885 (case 295) Household smoking Laboratory-confirmed
diagnosis
Daycare attendance, crowding
index, number of children under
5 y old, maternal education,
annual household income, race
Fogarty et al.
(Ireland, 1995) [48]
Case-control Population-based,
younger than 14 y
435 (case 149) Household smoking Laboratory-confirmed
diagnosis
Social class, bedroom sharing,
presence of chronic illness,
daycare attendance, youngest in
birth order, presence of school
age sibling
Muhlemann et al.
(Switzerland,
1996) [51]
Case-control Population-based,
2–16 y
438 (case 102) Number of household
smoker
Laboratory-confirmed
and/or clinical diagnosis
Hib vaccination, daycare/
kindergarten/school attendance,
number of adult household
members and siblings, siblings
daycare/school attendance,
bedroom sharing
Silfverdal et al.
(Sweden, 1997) [52]
Case-control Population-based,
,6y
193 (case 54) Household smoking Laboratory-confirmed
diagnosis
Socioeconomic status, number of
siblings, breastfeeding, daycare
attendance, history of chronic
allergy or recurrent infection
Wolff et al. (USA,
1999) [53]
Case-control Population-based,
,2y
176 (case 60) Parental or caretaker
smoking
Laboratory-confirmed
diagnosis
Only unadjusted ORs reported
Jafari et al. (USA,
1999) [49]
Case-control Population-based,
multistate, 2–16 mo
133 (case 40) At least one household
smoker
Laboratory-confirmed
diagnosis
Only unadjusted ORs reported
Pereiro et al.
(Spain, 2004) [36]
Case-control Hospital-based,
,5y
154 (case 31) Number of household
smokers
Laboratory-confirmed
diagnosis
More than four household
members, Hib vaccination
McVernon et al.
(UK, 2008) [50]
Case-control Population based,
,7y
428 (case 138) Household smoking Laboratory-confirmed
diagnosis
Prematurity, breastfeeding,
antibiotic use, number of
children in nursery, number of
siblings, bedroom sharing, single
parent household, central
heating, home ownership, Hib
vaccination
Hib carriage
Ayyildiz et al.
(Turkey 2003) [64]
Cross-sectional
survey
Population based, 7–
12 y
300 (case 9) Household smoking Nasopharyngeal carriage Only unadjusted ORs reported
Oguzkaya-Artan et al.
(Turkey, 2007) [65]
Cross-sectional
survey
Population based, 5–
7y
683 (case 29) Household smoking Oropharyngeal or lower
nasopharyngeal carriage
Sex, recent upper respiratory
tract infection, number in the
household, kindergarten
attendance
aIndividual studies have used different phrasing of exposure metrics. We have used ‘‘household smoking’’ in all cases where the definition was equivalent to smoking by
household members or smoking at home.
bWe defined a study as having laboratory-confirmed diagnosis if the study had more than 80% of cases confirmed by a positive culture, rapid antigen test, or PCR-based
identification. Other studies were classified as a mix of laboratory-confirmed and clinical diagnosis.
cThe reference category was children with no SHS exposure and the exposed group was divided into multiple categories. The OR for the highest category was used in
the meta-analysis. See Results for further information about dose-response.
dParticipants were enrolled in a prospective cohort study but the data for this analysis were from a cross-sectional swab, i.e., no time-to-event analysis.
ICD, International Classification of Diseases.
doi:10.1371/journal.pmed.1000374.t001
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disease, (B) pneumococcal disease, (C) Hib disease.
doi:10.1371/journal.pmed.1000374.g002
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analysis [3,44–47].
SHS Exposure and Pharyngeal Bacterial Carriage
N. meningitidis carriage. We identified a total of five cross-
sectional surveys on pharyngeal carriage of N. meningitidis
comprising 2,575 carriers and 15,624 noncarriers (Table 1) [54–
58]. The pooled OR for all studies showed a significant positive
association between SHS exposure and pharyngeal N. meningitidis
carriage (pooled OR 1.67, 95% CI 1.12–2.52; test of heterogeneity
p=0.034, I
2=61.6%) [54–58] (Figure 3A). Studies with
multivariate adjustment had an OR smaller than the overall
analysis, but their pooled effect size remained significant (1.17
[1.05–1.30]) (Table 2) [57]. However, meta-regression analysis
indicated that the difference between adjusted and crude effect
sizes had borderline statistical significance (p=0.061).
S. pneumoniae carriage. There were five cross-sectional
surveys on SHS exposure and pharyngeal carriage of S. pneumoniae
Table 2. Summary of subgroup analysis of studies of the association of SHS and IBD or pharyngeal bacterial carriage.
Category
Number of
Studies
Summary Estimate
(95% CI) I
2 (95% CI)
Meta-regression
p-Value
Invasive meningococcal disease
All studies [25–34,36–41,84] 16 2.02 (1.52–2.69) 68.5% (47.2–81.2) —
Laboratory-confirmed diagnosis [27,28,31–33,39] 6 3.24 (1.72–6.13) 63.5% (11.7–84.9) 0.149
Adjusted analysis [25–28,30–34,36–40] 11 2.18 (1.55–3.06) 66.8% (37.3–82.4) 0.500
Unadjusted analysis [29,30,39–41] 5 1.78 (0.97–3.24) 75.4% (32.1–84.7) 0.500
Adjusted for crowding, household density or room sharing
[25,27,28,32,34,36–38]
8 1.96 (1.36–2.82) 67.7% (34.6–93.5) 0.858
Adjusted for vaccination status [26,31,36] 3 2.21 (1.41–3.46) 48.6% (0–85.0) 0.468
Adjusted for breastfeeding [33,34] 2 2.38 (0.19–29.32) 87.4% 0.894
Age less than 6 y 3 3.04 (0.88–10.47) 79.4% (34.6–93.5) 0.591
Meningococcal carriage
All studies [54–58] 5 1.67 (1.12–2.52) 61.6% (0–85.6) —
Adjusted analysis [57] 1 1.17 (1.05–1.30) — 0.061
Unadjusted analysis [54–56,58] 4 2.07 (1.43–2.99) 0% (0–84.7) 0.061
Invasive pneumococcal disease
All studies [35,36,42,43] 4 1.21 (0.69–2.14) 52.3% (0–84.2) —
Laboratory-confirmed diagnosis [36,42,43] 3 0.93 (0.62–1.41) 0% (0–89.6) 0.170
Adjusted analysis [35] 1 2.99 (1.10–.8.14) — 0.170
Unadjusted analysis [36,42,43] 3 0.93 (0.62–1.41) 0% (0–89.6) 0.170
Age less than 6 y [35,42] 2 1.68 (0.61–4.66) 62.4% 0.461
Studies prior to 2000 [35,36,43] 3 1.33 (0.58–3.02) 68.1% (0–90.8) 0.803
Pneumococcal carriage
All studies [59–63] 5 1.66 (1.33–2.07) 0% (0–79.2) —
Adjusted analysis [59,60,62] 3 1.48 (1.01–2.16) 26.4% (0–92.4) 0.519
Unadjusted analysis [61,63] 2 1.76 (1.34–2.31) 0% 0.519
Age less than 6 y [60,61,63] 3 1.63 (1.27–2.01) 12.7% (0–86.7) 0.807
Invasive Hib disease
All studies [3,36,44–53] 12 1.22 (0.93–1.62) 55.0% (13.8–76.5) —
Laboratory-confirmed diagnosis [3,36,44,46–50,52,53] 10 1.24 (0.86–1.78) 62.7% (26.2–81.2) 0.929
Adjusted analysis [3,36,44,47,48,50–52] 8 1.10 (0.80–1.51) 56.5% (4.2–80.2) 0.269
Unadjusted analysis [45,46,49,53] 4 1.70 (0.90–3.20) 53.0% (0–84.6) 0.269
Adjusted for crowding, household density or room sharing
[36,44,47,48,50,51]
6 1.05 (0.76–1.46) 52.3% (0–81.0) 0.241
Adjusted for vaccination status [36,47,50] 3 1.20 (0.70–2.04) 66.9% (0–90.45) 0.915
Adjusted for breastfeeding [3,47,50,52] 4 1.13 (0.63–1.98) 69.2% (11.0–89.3) 0.714
Age less than 6 y [3,36,44–47,49,52,53] 9 1.46 (1.19–1.81) 38.5% (0–71.7) 0.035
Studies prior to 1990 [3,44–47] 5 1.49 (1.16–1.93) 44.9% (0–79.8) 0.168
Hib carriage
All studies [64,65] 2 0.96 (0.48–1.95) 0% —
Unadjusted analysis[65] 1 0.89 (0.42–1.89) — —
doi:10.1371/journal.pmed.1000374.t002
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The pooled result from all studies showed a significant positive
association (pooled OR 1.66, 95% CI 1.33–2.07; test of heterogeneity
p=0.48, I
2=0%) (Figure 3B). Adjustment or study characteristics did
not significantly modify the effect size in meta-regression analysis
(Table 2). Subgroup analysis on the three studies with multivariate
Figure 3. ORs for pharyngeal carriage of bacteria for exposure to secondhand smoke compared to nonexposure: (A) N. meningitidis,
(B) S. pneumonia, (C) Hib.
doi:10.1371/journal.pmed.1000374.g003
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(OR 1.48, 95% CI 1.01–2.16) [59,60,62]. Studies on preschool
children also had a significant association of similar magnitude (OR
1.63, 95% CI 1.27–2.10) (Table 2) [60,61,63].
Hib carriage. T h e r ew e r eo n l yt w oc r o s s - s e c t i o n a ls t u d i e so n
SHS exposure and childhood pharyngeal carriage of Hib that included
a total of 38 cases and 945 controls (Table 1) [64,65]. The pooled
association was nonsignificant (OR 0.96, 95% CI 0.48–1.95; test of
heterogeneity p=0.56, I
2=0%) (Figure 3C). The study population did
not include the most vulnerable age group, i.e., preschool children.
Dose-Response Relationships
Dose-response relationships were examined in four invasive
meningococcal disease studies [28,32,36,39], three invasive Hib
disease studies [47,50,51], and one invasive pneumococcal disease
study [36]. The studies had used different metrics to measure
exposure and dose including number of cigarettes smoked per day
and number of household smokers. The absence of a consistent
definition of exposure meant that a pooled analysis of the dose-
response relationship was not possible. Broadly, with the exception of
the pneumococcal study and one Hib study, there was a dose-
response relationship with the number of cigarettes smoked per day
or the number of smokers in the household [28,32,36,39,47,50,51].
Publication Bias
The test for publication bias was significant in three of the six
outcomes, namely invasive meningococcal and pneumococcal diseases
and N. meningitidis carriage (Table 3). The trim-and-fill ORs for
meningococcal disease and N. meningitidis carriage were lower but the
former remained statistically significant. The positive, but nonsignif-
icant, OR of 1.21 (95% CI 0.69–2.14) for pneumococcal disease was
replaced by a trim-and-fill OR of 0.83 (95% CI 0.45–1.53).
Discussion
This systematic review and meta-analysis of studies on the
association between SHS exposure and IBD or pharyngeal
carriage of pathogenic bacteria in pediatric populations revealed
a consistent and positive association between SHS exposure and
invasive meningococcal disease and pharyngeal carriage of N.
meningitidis, as well as a positive association with S. pneumoniae
carriage. There was also a positive but not statistically significant
association with invasive pneumococcal and Hib diseases. The
association with Hib carriage was based on only two studies and
was null. When subanalyses could be conducted, the pooled effect
sizes with and without adjustment for important risk factors were
generally similar, becoming slightly smaller for meningococcal and
pneumococcal carriage and for invasive Hib disease, and larger for
invasive meningococcal and pneumococcal diseases. Studies with
laboratory-confirmed diagnosis, the more rigorous outcome, had
large and statistically significant effect sizes for meningococcal
disease but not for pneumococcal and Hib diseases.
The nonsignificant associations with invasive pneumococcal
disease may have been partially due to the relatively small pooled
sample sizes (412 cases), whereas that of Hib disease is less likely to
be due to sample size (1,228 cases). For Hib disease, studies on the
most vulnerable ages (#6 y old) had larger and significant effect
estimates. A factor that may have contributed to the insignificant
effects may be the increasing use of Hib vaccine (since 1990) and
pneumococcal conjugate vaccines (since 2000). Studies before the
vaccine era had larger effect sizes for both Hib and pneumococcal
diseases, but these were only statistically significant for Hib. These
factors, and the strong association that has been observed between
active smoking and invasive pneumococcal disease [66], should
motivate additional high-quality studies with large sample sizes to
clarify the role of SHS in the etiology of invasive pneumococcal
disease.
There are plausible mechanisms for the effects of SHS on
bacterial diseases. Both in vivo and in vitro experimental studies have
found that SHS exposure may induce structural changes in the
respiratory tract including peribronchiolar inflammation and
fibrosis, increased mucosal permeability, and impairment of the
mucociliary clearance [67,68]. It may also decrease immune
defenses, e.g., a decreased level and depressed responses of
circulating immunoglobulins, decreased CD4+ lymphocyte counts
and increased CD8+ lymphocyte counts, depressed phagocyte
activity, and decreased release of proinflammatory cytokines [68–
72]. All these mechanisms might increase the risk of bacterial
invasion and subsequent infection. The significant findings here
regarding the association of SHS exposure with bacterial carriage
also support a plausible etiological role for SHS in invasive
bacterial disease, because asymptomatic carriage is an intermedi-
ate step towards invasive disease [12,13,15,16]. Asymptomatic
carriage itself has a public health implication because it is
important in population transmission of infectious bacteria[12,15].
Strengths and Limitations
This systematic review has strengths and limitations. To the best
of our knowledge, this is the first systematic review of the
epidemiologic evidence on the association between SHS exposure
and pediatric IBD. We were able to include clinical invasive
disease as well as the etiologically and epidemiologically important
intermediate stage of asymptomatic bacterial carriage. As far as
possible, we assessed sensitivity to important methodological
Table 3. Tests for publication bias and trim-and-fill ORs.
Outcome Begg p-Value Egger p-Value Original OR (95% CI)
a Trim and Fill OR (95% CI)
Invasive meningococcal disease 0.015 0.060 2.02 (1.52–2.69) 1.66 (1.22–2.24)
Meningococcal carriage 0.624 0.065 1.67 (1.12–2.52) 1.32 (0.91–1.92)
Invasive pneumococcal disease 0.042 0.012 1.21 (0.69–2.14) 0.83 (0.45–1.53)
Pneumococcal carriage 0.327 0.255 1.66 (1.33–2.07) NA
Invasive Hib disease 0.537 0.777 1.22 (0.93–1.62) NA
Hib carriage 0.317 NA 0.96 (0.48–1.95) NA
Trim-and-fill ORs were calculated when publication bias tests were statistically significant.
aFrom Figure 2.
NA, not applicable.
doi:10.1371/journal.pmed.1000374.t003
SHS and Pediatric Invasive Bacterial Disease
PLoS Medicine | www.plosmedicine.org 10 December 2010 | Volume 7 | Issue 12 | e1000374design and quality characteristics using meta-regression and
subgroup analysis. Our search covered multiple databases without
language limitation.
A key limitation of our study was the relatively small number of
studies, specifically from developing countries in which the IBD
burden is the largest, smoking is increasing, and vaccination
coverage may be lower. Notably, two African studies had a
nonsignificant effect size for invasive meningococcal disease
[30,34]. One of these studies was from northern Ghana, where
more than 93% of participants were exposed to fuelwood smoke
[30]. In addition, negative residual confounding (due to the
potential negative association of household smoking with econom-
ic status) cannot be ruled out as a source of the nonsignificant
negative finding. The second study, from urban South Africa, had
included an interaction term between recent upper respiratory
tract infection (URTI) and SHS exposure in the multivariate
analysis, which had an OR of 3.6 (95% CI 1.4–7.3) [34]. If recent
URTI itself was caused by SHS and can increase the risk of IBD,
then this adjustment would attenuate the true effect of the SHS
term. A third African study from The Gambia had an OR of 2.99
(95% CI 1.10–8.14) for pneumococcal disease [35]. The limited
number of studies from developing countries makes it difficult to
assess the role of factors such as background incidence rate,
nutritional status, vaccination, and coexposure to wood smoke on
the ORs for SHS-IBD association. A second potential limitation is
that both the exposure and outcome measurements may have
been subject to error, which is likely to have biased our results
towards the null and reduced its significance. Third, heterogeneity
of effect sizes across studies restricts our ability and confidence to
generalize the results of this pooled data analysis to all populations.
Fourth, the studies on association with bacterial carriage were
distinct from those on IBD and no SHS-IBD studies had assessed
carriage at baseline. As a result, we were not able to assess whether
SHS exposure only increases the risk for colonization, or increases
the risk of subsequent infection, or both. Fifth, because IBD is a
complex disease with multiple causes, there is potential for residual
confounding in the observational studies included in our analysis.
This is especially relevant given that the currently available SHS-
IBD studies were case-control or nested case-control studies and
those on SHS-bacterial carriage were cross-sectional studies. Our
findings on the potential causal associations should motivate new
prospective studies. Sixth, our study focused on pediatric SHS
exposure and did not assess studies on perinatal SHS exposure as a
risk factor for IBD, with some of the effect possibly mediated
through low birth weight. [73,74]. Finally, while we assessed the
potential for publication bias and report trim-and-fill ORs, the
latter estimates are themselves subject to methodologic limitations
especially when the number of studies is small [75].
Despite the limitations of current epidemiologic studies, our
meta-analysis provides some evidence of an association between
SHS and IBD and pharyngeal carriage, especially in preschool
children. Although there are efficacious vaccines against all three
pathogens assessed in this study, many children in low-income
countries are not covered in routine immunizations and have
limited access to case management [76–80]. Vaccine pricing
remains an obstacle to uptake, while waning immunity and
serotype replacement may undermine long-term vaccine effective-
ness [78,81–83]. Thus scaling up vaccine coverage and case
management must be accompanied by nonvaccine interventions,
such as environmental interventions, to address the large burden
of IBDs. Tobacco smoking and SHS exposure have increased in
low-income and middle-income countries, making SHS exposure
a global problem [84,85]. While public smoking bans have been
effective in reducing adult SHS exposure and adverse health
effects [86,87], children’s exposure to SHS may occur at home,
where bans may be difficult to enforce [11]. An estimated 700
million children worldwide are exposed to SHS at home [84]. If
the observed effects are causal, our results indicate that in a
population where 25% of young children are exposed to SHS (e.g.,
Brazil or South Africa), 5%–20% of IBD cases may be attributable
to this risk factor; the attributable fraction would be 10%–34% in
populations where exposure is 50% (e.g., Egypt or Indonesia).
Effects of such magnitude should motivate a number of research
and intervention steps specifically related to SHS and pediatric
IBD: Firstly, there should be well-designed prospective studies with
high-quality measurement of exposure, outcome, and potential
confounders to overcome the limitations of the current studies.
Secondly, interventions that specifically focus on reducing
children’s exposure at home, schools, and other environments
should be pursued. These two directions are particularly important
in developing countries where the IBD burden is high and
exposure to SHS is high or increasing. Finally, the effects of other
combustion pollutant sources that are common in developing
countries, especially smoke from wood and animal dung fuels, on
IBD should be subject to research.
Supporting Information
Text S1 PRISMA checklist.
Found at: doi:10.1371/journal.pmed.1000374.s001 (0.07 MB
DOC)
Acknowledgment
We thank Hsien-Ho Lin for valuable comments.
Author Contributions
ICMJE criteria for authorship read and met: CCL NAM SRCH ME.
Agree with the manuscript’s results and conclusions: CCL NAM SRCH
ME. Designed the experiments/the study: CCL ME. Analyzed the data:
CCL NAM SRCH. Collected data/did experiments for the study: CCL
NAM. Wrote the first draft of the paper: CCL ME. Contributed to the
writing of the paper: NAM SRCH. Developed research concept and
oversaw research: ME.
References
1. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, et al. (2005) Bacteremia
among children admitted to a rural hospital in Kenya. N Engl J Med 352: 39–47.
2. Brent AJ, Ahmed I, Ndiritu M, Lewa P, Ngetsa C, et al. (2006) Incidence of
clinically significant bacteraemia in children who present to hospital in Kenya:
community-based observational study. Lancet 367: 482–488.
3. Harrison LH, Broome CV, Hightower AW (1989) Haemophilus influenzae type
b polysaccharide vaccine: an efficacy study. Haemophilus Vaccine Efficacy
Study Group. Pediatrics 84: 255–261.
4. Kaijalainen T, Kharit SM, Kvetnaya AS, Sirkia K, Herva E, et al. (2008)
Invasive infections caused by Neisseria meningitidis, Haemophilus influenzae
and Streptococcus pneumoniae among children in St Petersburg, Russia. Clin
Microbiol Infect 14: 507–510.
5. Mulholland EK, Adegbola RA (2005) Bacterial infections–a major cause of
death among children in Africa. N Engl J Med 352: 75–77.
6. O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. (2009)
Burden of disease caused by Streptococcus pneumoniae in children younger
than 5 years: global estimates. Lancet 374: 893–902.
7. Watt JP, Wolfson LJ, O’Brien KL, Henkle E, Deloria-Knoll M, et al. (2009)
Burden of disease caused by Haemophilus influenzae type b in children younger
than 5 years: global estimates. Lancet 374: 903–911.
8. World Health Organization (2005) Make every mother and child count. Geneva:
World Health Organization.
9. Harrison LH, Trotter CL, Ramsay ME (2009) Global epidemiology of
meningococcal disease. Vaccine 27 Suppl 2: B51–63.
SHS and Pediatric Invasive Bacterial Disease
PLoS Medicine | www.plosmedicine.org 11 December 2010 | Volume 7 | Issue 12 | e100037410. California Environmental Protection Agency (2005) Proposed Identification of
Environmental Tobacco Smoke as a TAC; Office of Environmental Health
Hazard Assessment CEPA, editor. Sacramento: California Environmental
Protection Agency.
11. Office of the Surgeon General (2006) The health consequences of involuntary
exposure to tobacco smoke: a report of the Surgeon General; Department of
Health and Human Services C, editor. Atlanta (Georgia): Office of the Surgeon
General.
12. Bogaert D, De Groot R, Hermans PW (2004) Streptococcus pneumoniae
colonization: the key to pneumococcal disease. Lancet Infect Dis 4: 144–154.
13. Gray BM, Converse GM, III, Dillon HC, Jr. (1980) Epidemiologic studies of
Streptococcus pneumoniae in infants: acquisition, carriage, and infection during
the first 24 months of life. J Infect Dis 142: 923–933.
14. Lloyd-Evans N, O’Dempsey TJ, Baldeh I, Secka O, Demba E, et al. (1996)
Nasopharyngeal carriage of pneumococci in Gambian children and in their
families. Pediatr Infect Dis J 15: 866–871.
15. van der Poll T, Opal SM (2009) Pathogenesis, treatment, and prevention of
pneumococcal pneumonia. Lancet 374: 1543–1556.
16. van Deuren M, Brandtzaeg P, van der Meer JW (2000) Update on
meningococcal disease with emphasis on pathogenesis and clinical management.
Clin Microbiol Rev 13: 144–166, table of contents.
17. Vergnano S, Sharland M, Kazembe P, Mwansambo C, Heath PT (2005)
Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed
90: F220–F224.
18. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for
systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med
151: 264–269, W264.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring
inconsistency in meta-analyses. BMJ 327: 557–560.
20. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin
Trials 7: 177–188.
21. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis.
Stat Med 21: 1539–1558.
22. Galbraith RF (1988) A note on graphical presentation of estimated odds ratios
from several clinical trials. Stat Med 7: 889–894.
23. Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of
testing and adjusting for publication bias in meta-analysis. Biometrics 56:
455–463.
24. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis
detected by a simple, graphical test. BMJ 315: 629–634.
25. Baker M, McNicholas A, Garrett N, Jones N, Stewart J, et al. (2000) Household
crowding a major risk factor for epidemic meningococcal disease in Auckland
children. Pediatr Infect Dis J 19: 983–990.
26. Coen PG, Tully J, Stuart JM, Ashby D, Viner RM, et al. (2006) Is it exposure to
cigarette smoke or to smokers which increases the risk of meningococcal disease
in teenagers? Int J Epidemiol 35: 330–336.
27. Fischer M, Hedberg K, Cardosi P, Plikaytis BD, Hoesly FC, et al. (1997)
Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J
16: 979–983.
28. Grein T, O’Flanagan D (2001) Day-care and meningococcal disease in young
children. Epidemiol Infect 127: 435–441.
29. Haneberg B, Tonjum T, Rodahl K, Gedde-Dahl TW (1983) Factors preceding
the onset of meningococcal disease, with special emphasis on passive smoking,
symptoms of ill health. NIPH Ann 6: 169–173.
30. Hodgson A, Smith T, Gagneux S, Adjuik M, Pluschke G, et al. (2001) Risk
factors for meningococcal meningitis in northern Ghana. Trans R Soc Trop
Med Hyg 95: 477–480.
31. Honish L, Soskolne CL, Senthilselvan A, Houston S (2008) Modifiable risk
factors for invasive meningococcal disease during an Edmonton, Alberta
outbreak, 1999-2002. Can J Public Health 99: 46–51.
32. Kriz P, Bobak M, Kriz B (2000) Parental smoking, socioeconomic factors, and
risk of invasive meningococcal disease in children: a population based case-
control study. Arch Dis Child 83: 117–121.
33. McCall BJ, Neill AS, Young MM (2004) Risk factors for invasive meningococcal
disease in southern Queensland, 2000-2001. Intern Med J 34: 464–468.
34. Moodley JR, Coetzee N, Hussey G (1999) Risk factors for meningococcal disease
in Cape Town. S Afr Med J 89: 56–59.
35. O’Dempsey TJ, McArdle TF, Morris J, Lloyd-Evans N, Baldeh I, et al. (1996) A
study of risk factors for pneumococcal disease among children in a rural area of
west Africa. Int J Epidemiol 25: 885–893.
36. Pereiro I, Diez-Domingo J, Segarra L, Ballester A, Albert A, et al. (2004) Risk
factors for invasive disease among children in Spain. J Infect 48: 320–329.
37. Robinson P, Taylor K, Nolan T (2001) Risk-factors for meningococcal disease in
Victoria, Australia, in 1997. Epidemiol Infect 127: 261–268.
38. Sørensen HT, Labouriau R, Jensen ES, Mortensen PB, Schønheyder HC (2004)
Fetal growth, maternal prenatal smoking, and risk of invasive meningococcal
disease: a nationwide case-control study. Int J Epidemiol 33: 816–820.
39. Stanwell-Smith RE, Stuart JM, Hughes AO, Robinson P, Griffin MB, et al.
(1994) Smoking, the environment and meningococcal disease: a case control
study. Epidemiol Infect 112: 315–328.
40. Stuart JM, Cartwright KA, Dawson JA, Rickard J, Noah ND (1988) Risk factors
for meningococcal disease: a case control study in south west England.
Community Med 10: 139–146.
41. Tully J, Viner RM, Coen PG, Stuart JM, Zambon M, et al. (2006) Risk and
protective factors for meningococcal disease in adolescents: matched cohort
study. BMJ. pp 445–450.
42. Haddad MB, Porucznik CA, Joyce KE, De AK, Pavia AT, et al. (2008) Risk
factors for pediatric invasive pneumococcal disease in the Intermountain West,
1996-2002. Ann Epidemiol 18: 139–146.
43. Takala AK, Jero J, Kela E, Ronnberg PR, Koskenniemi E, et al. (1995) Risk
factors for primary invasive pneumococcal disease among children in Finland.
JAMA 273: 859–864.
44. Arnold C, Makintube S, Istre GR (1993) Day care attendance and other risk
factors for invasive Haemophilus influenzae type b disease. Am J Epidemiol 138:
333–340.
45. Cochi SL, Fleming DW, Hightower AW, Limpakarnjanarat K, Facklam RR,
et al. (1986) Primary invasive Haemophilus influenzae type b disease: a
population-based assessment of risk factors. J Pediatr 108: 887–896.
46. Takala AK, Eskola J, Palmgren J, Ronnberg PR, Kela E, et al. (1989) Risk
factors of invasive Haemophilus influenzae type b disease among children in
Finland. J Pediatr 115: 694–701.
47. Vadheim CM, Greenberg DP, Bordenave N, Ziontz L, Christenson P, et al.
(1992) Risk factors for invasive Haemophilus influenzae type b in Los Angeles
County children 18-60 months of age. Am J Epidemiol 136: 221–235.
48. Fogarty J, Moloney AC, Newell JB (1995) The epidemiology of Haemophilus
influenzae type b disease in the Republic of Ireland. Epidemiol Infect 114:
451–463.
49. Jafari HS, Adams WG, Robinson KA, Plikaytis BD, Wenger JD (1999) Efficacy
of Haemophilus influenzae type b conjugate vaccines and persistence of disease
in disadvantaged populations. The Haemophilus Influenzae Study Group.
Am J Public Health 89: 364–368.
50. McVernon J, Andrews N, Slack M, Moxon R, Ramsay M (2008) Host and
environmental factors associated with Hib in England, 1998-2002. Arch Dis
Child 93: 670–675.
51. Muhlemann K, Alexander ER, Weiss NS, Pepe M, Schopfer K (1996) Risk
factors for invasive Haemophilus influenzae disease among children 2-16 years
of age in the vaccine era, Switzerland 1991-1993. The Swiss H. Influenzae Study
Group. Int J Epidemiol 25: 1280–1285.
52. Silfverdal SA, Bodin L, Hugosson S, Garpenholt O, Werner B, et al. (1997)
Protective effect of breastfeeding on invasive Haemophilus influenzae infection:
a case-control study in Swedish preschool children. Int J Epidemiol 26: 443–450.
53. Wolff MC, Moulton LH, Newcomer W, Reid R, Santosham M (1999) A case-
control study of risk factors for Haemophilus influenzae type B disease in Navajo
children. Am J Trop Med Hyg 60: 263–266.
54. Davies AL, O’Flanagan D, Salmon RL, Coleman TJ (1996) Risk factors for
Neisseria meningitidis carriage in a school during a community outbreak of
meningococcal infection. Epidemiol Infect 117: 259–266.
55. Kremastinou J, Blackwell C, Tzanakaki G, Kallergi C, Elton R, et al. (1994)
Parental smoking and carriage of Neisseria meningitidis among Greek
schoolchildren. Scand J Infect Dis 26: 719–723.
56. Kremastinou J, Tzanakaki G, Velonakis E, Voyiatzi A, Nickolaou A, et al. (1999)
Carriage of Neisseria meningitidis and Neisseria lactamica among ethnic Greek
school children from Russian immigrant families in Athens. FEMS Immunol
Med Microbiol 23: 13–20.
57. MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, et al. (2006) Social
behavior and meningococcal carriage in British teenagers. Emerg Infect Dis 12:
950–957.
58. Stuart JM, Cartwright KA, Robinson PM, Noah ND (1989) Effect of smoking
on meningococcal carriage. Lancet 2: 723–725.
59. Cardozo DM, Nascimento-Carvalho CM, Andrade AL, Silvany-Neto AM,
Daltro CH, et al. (2008) Prevalence and risk factors for nasopharyngeal carriage
of Streptococcus pneumoniae among adolescents. J Med Microbiol 57: 185–189.
60. Coles CL, Kanungo R, Rahmathullah L, Thulasiraj RD, Katz J, et al. (2001)
Pneumococcal nasopharyngeal colonization in young South Indian infants.
Pediatr Infect Dis J 20: 289–295.
61. Greenberg D, Givon-Lavi N, Broides A, Blancovich I, Peled N, et al. (2006) The
contribution of smoking and exposure to tobacco smoke to Streptococcus
pneumoniae and Haemophilus influenzae carriage in children and their
mothers. Clin Infect Dis 42: 897–903.
62. Labout JA, Duijts L, Arends LR, Jaddoe VW, Hofman A, et al. (2008) Factors
associated with pneumococcal carriage in healthy Dutch infants: the generation
R study. J Pediatr 153: 771–776.
63. Sung RY, Ling JM, Fung SM, Oppenheimer SJ, Crook DW, et al. (1995)
Carriage of Haemophilus influenzae and Streptococcus pneumoniae in healthy
Chinese and Vietnamese children in Hong Kong. Acta Paediatr 84: 1262–1267.
64. Ayyildiz A, Aktas AE, Yazgi H (2003) Nasopharyngeal carriage rate of
Haemophilus influenzae in children aged 7-12 years in Turkey. Int J Clin Pract
57: 686–688.
65. Oguzkaya-Artan M, Baykan Z, Artan C (2008) Nasal carriage of Staphylococcus
aureus in healthy preschool children. Jpn J Infect Dis 61: 70–72.
66. Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, et al. (2000)
Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core
Surveillance Team. N Engl J Med 342: 681–689.
67. Dye JA, Adler KB (1994) Effects of cigarette smoke on epithelial cells of the
respiratory tract. Thorax 49: 825–834.
68. Wanner A, Salathe ´ M, O’Riordan TG (1996) Mucociliary clearance in the
airways. Am J Respir Crit Care Med 154: 1868–1902.
SHS and Pediatric Invasive Bacterial Disease
PLoS Medicine | www.plosmedicine.org 12 December 2010 | Volume 7 | Issue 12 | e100037469. Arcavi L, Benowitz NL (2004) Cigarette smoking and infection. Arch Intern
Med 164: 2206–2216.
70. Gaschler GJ, Zavitz CC, Bauer CM, Skrtic M, Lindahl M, et al. (2008) Cigarette
smoke exposure attenuates cytokine production by mouse alveolar macrophages.
Am J Respir Cell Mol Biol 38: 218–226.
71. Green RM, Gally F, Keeney JG, Alper S, Gao B, et al. (2009) Impact of cigarette
smoke exposure on innate immunity: a Caenorhabditis elegans model. PLoS
One 4: e6860. doi:10.1371/journal.pone.0006860.
72. Martı ´-Lliteras P, Regueiro V, Morey P, Hood DW, Saus C, et al. (2009)
Nontypeable Haemophilus influenzae clearance by alveolar macrophages is
impaired by exposure to cigarette smoke. Infect Immun 77: 4232–4242.
73. Sorensen HT, Labouriau R, Jensen ES, Mortensen PB, Schonheyder HC (2004)
Fetal growth, maternal prenatal smoking, and risk of invasive meningococcal
disease: a nationwide case-control study. Int J Epidemiol 33: 816–820.
74. Yusuf HR, Rochat RW, Baughman WS, Gargiullo PM, Perkins BA, et al. (1999)
Maternal cigarette smoking and invasive meningococcal disease: a cohort study
among young children in metropolitan Atlanta, 1989-1996. Am J Public Health
89: 712–717.
75. Moreno SG, Sutton AJ, Turner EH, Abrams KR, Cooper NJ, et al. (2009)
Novel methods to deal with publication biases: secondary analysis of
antidepressant trials in the FDA trial registry database and related journal
publications. BMJ 339: b2981.
76. Centers for Disease Control and Prevention (CDC) (2005) Direct and indirect
effects of routine vaccination of children with 7-valent pneumococcal conjugate
vaccine on incidence of invasive pneumococcal disease–United States, 1998-
2003. MMWR Morb Mortal Wkly Rep 54: 893–897.
77. De Wals P, Deceuninck G, Boulianne N, De Serres G (2004) Effectiveness of a
mass immunization campaign using serogroup C meningococcal conjugate
vaccine. JAMA 292: 2491–2494.
78. Levine OS, O’Brien KL, Knoll M, Adegbola RA, Black S, et al. (2006)
Pneumococcal vaccination in developing countries. Lancet 367: 1880–1882.
79. Lim SS, Stein DB, Charrow A, Murray CJ (2008) Tracking progress towards
universal childhood immunisation and the impact of global initiatives: a
systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation
coverage. Lancet 372: 2031–2046.
80. Morris SK, Moss WJ, Halsey N (2008) Haemophilus influenzae type b conjugate
vaccine use and effectiveness. Lancet Infect Dis 8: 435–443.
81. Madhi SA, Adrian P, Kuwanda L, Cutland C, Albrich WC, et al. (2007) Long-
term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization
by Streptococcus pneumoniae–and associated interactions with Staphylococcus
aureus and Haemophilus influenzae colonization–in HIV-Infected and HIV-
uninfected children. J Infect Dis 196: 1662–1666.
82. Madhi SA, Adrian P, Kuwanda L, Jassat W, Jones S, et al. (2007) Long-term
immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in
human immunodeficient virus infected and non-infected children in the absence
of a booster dose of vaccine. Vaccine 25: 2451–2457.
83. Obaro SK, Adegbola RA, Banya WA, Greenwood BM (1996) Carriage of
pneumococci after pneumococcal vaccination. Lancet 348: 271–272.
84. World Health Organization (2009) WHO Report on the Global Tobacco
Epidemic: implementing smoke-free environments. Geneva: World Health
Organization.
85. Jha P, Chaloupka FJ, eds (2000) Tobacco control in developing countries.
Oxford: Oxford University Press.
86. Lightwood JM, Glantz SA (2009) Declines in acute myocardial infarction after
smoke-free laws and individual risk attributable to secondhand smoke.
Circulation 120: 1373–1379.
87. Sargent RP, Shepard RM, Glantz SA (2004) Reduced incidence of admissions
for myocardial infarction associated with public smoking ban: before and after
study. BMJ 328: 977–980.
SHS and Pediatric Invasive Bacterial Disease
PLoS Medicine | www.plosmedicine.org 13 December 2010 | Volume 7 | Issue 12 | e1000374Editors’ Summary
Background. The deleterious health effects of smoking on
smokers are well established, but smoking also seriously
damages the health of nonsmokers. Secondhand smoke
(SHS), which is released by burning cigarettes and exhaled by
smokers, contains hundreds of toxic chemicals that increase
the risk of adults developing lung cancer and heart disease.
Children, however, are particularly vulnerable to the effects
of SHS exposure (also known as passive smoking) because
they are still developing physically. In addition, children have
little control over their indoor environment and thus can be
heavily exposed to SHS. Exposure to SHS increases the risk of
ear infections, asthma, respiratory symptoms (coughing,
sneezing, and breathlessness), and lung infections such as
pneumonia and bronchitis in young children and the risk of
sudden infant death syndrome during the first year of life.
Why Was This Study Done? Several studies have also
shown an association between SHS exposure (which
damages the lining of the mouth, throat, and lungs and
decreases immune defenses) and potentially fatal invasive
bacterial disease (IBD) in children. In IBD, bacteria invade the
body and grow in normally sterile sites such as the blood
(bacteremia) and the covering of the brain (meningitis).
Three organisms are mainly responsible for IBD in children—
Streptococcus pneumoniae, Haemophilus influenzae type B
(Hib), and Neisseria meningitidis. In 2000, S. pneumonia
(pneumococcal disease) alone killed nearly one million
children. Here, the researchers undertake a systematic
review and meta-analysis of the association between SHS
exposure in children and two outcomes—IBD and the
presence of IBD-causing organisms in the nose and throat
(bacterial carriage). A systematic review uses predefined
criteria to identify all the research on a given topic; meta-
analysis is a statistical method that combines the results of
several studies. By combining data, it is possible to get a
clearer view of the causes of a disease than is possible from
individual studies.
What Did the Researchers Do and Find? The researchers
identified 30 case-control studies that compared the
occurrence of IBD over time in children exposed to SHS
with its occurrence in children not exposed to SHS. They also
identified 12 cross-sectional studies that measured bacterial
carriage at a single time point in children exposed and not
exposed to SHS. The researchers used the data from these
studies to calculate a ‘‘summary odds ratio’’ (OR) for each
outcome—a measure of how SHS exposure affected the
likelihood of each outcome. Compared with children
unexposed to SHS, exposure to SHS doubled the likelihood
of invasive meningococcal disease (a summary OR for SHS
exposure of 2.02). Summary ORs for invasive pneumococcal
disease and Hib diseases were 1.21 and 1.22, respectively.
However, these small increases in the risk of developing
these IBDs were not statistically significant unlike the
increase in the risk of developing meningococcal disease.
That is, they might have occurred by chance. For bacterial
carriage, summary ORs for SHS exposure were 1.68 for N.
meningitidis, 1.66 for S. pneumonia (both these ORs were
statistically significant), and 0.96 for Hib (a nonsignificant
decrease in risk).
What Do These Findings Mean? These findings indicate
that SHS exposure is significantly associated with invasive
meningococcal disease among children. However, the
evidence that SHS exposure is associated with invasive
pneumococcal and Hib disease is only suggestive. These
findings also indicate that exposure to SHS is associated with
an increased carriage of N. meningitidis and S. pneumoniae.
The accuracy and generalizability of these findings is limited
by the small number of studies identified, by the lack of
studies from developing countries where SHS exposure is
increasing and the burden of IBD is high, and by large
variations between the studies in how SHS exposure was
measured and IBD diagnosed. Nevertheless, they suggest
that, by reducing children’s exposure to SHS (by, for
example, persuading parents not to smoke at home), the
illness and death caused by IBDs among children could be
greatly reduced. Such a reduction would be particularly
welcome in developing countries where vaccination against
IBDs is low.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000374.
N The US Centers for Disease Control and Prevention
provides information on secondhand smoke, on children
and secondhand smoke exposure, on meningitis, and on
Hib infection
N The US Environmental Protection Agency also provides
information on the health effects of exposure to second-
hand smoke (in English and Spanish) and a leaflet (also in
English and Spanish) entitled Secondhand Tobacco Smoke
and the Health of Your Family
N The US Office of the Surgeon General provides information
on the health consequences of involuntary exposure to
tobacco smoke
N The World Health Organization provides a range of
information on the global tobacco epidemic
N The World Health Organization has information on
meningococcal disease (in English only) and on Hib (in
several languages)
N The US National Foundation for Infectious Diseases
provides a fact sheet on pneumococcal disease
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